SPOTLIGHT -
Slideshow
Author(s):
Which of these agents best prevents relapse? A recent study employed a novel approach to find out.
Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists
Here's to a Psychedelic Revolution
Positive Phase 2 Results on NBI-1117568 for Schizophrenia Presented at 2025 ASCP Annual Meeting
Treating ‘Morally Objectionable’ Patients
From a Dysfunctional Neuromodulator to a Dysfunctional Circuit
Coordinated Specialty Care: Paving the Way for Psychosis Recovery